Skip to main content
Contact Us
Subscribe
E-Edition
52°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Entertainment
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Roche Holding AG Basel American Depositary Shares
(OP:
RHHBY
)
37.66
UNCHANGED
Streaming Delayed Price
Updated: 3:59 PM EST, Feb 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
37.66
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
37.66
Today's Range
37.66 - 37.66
52wk Range
37.30 - 53.86
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Here's What's Next For Biohaven After Its $12 Billion Pfizer Buyout, According To CEO Vlad Coric
February 02, 2023
The company that remains still has a large pipeline of non-migraine assets.
Via
Investor's Business Daily
Roche Flags Lower 2023 Sales On Declining Demand For COVID-19 Treatment, Diagnostics
February 02, 2023
Via
Benzinga
Performance
YTD
-4.10%
-4.10%
1 Month
-4.10%
-4.10%
3 Month
-7.94%
-7.94%
6 Month
-8.59%
-8.59%
1 Year
-22.78%
-22.78%
More News
Read More
Roche Introduces Test To Detect Contagious XBB.1.5 Omicron Sub-Variant
January 26, 2023
Via
Benzinga
Genentech's Tecentriq Plus Avastin Combo Cuts Risk of Cancer Returning In Early-Stage Liver Cancer
January 19, 2023
Via
Benzinga
Genentech’s Tecentriq Plus Avastin Is the First Treatment Combination to Reduce the Risk of Cancer Returning in People With Certain Types of Early-Stage Liver Cancer in a Phase III Trial
January 19, 2023
From
Genentech
Via
Business Wire
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December
January 17, 2023
Via
Benzinga
Europe Approves Xofluza, Roche's Revolutionary Influenza Antiviral with New Mechanism
January 12, 2023
Via
Benzinga
Biotech Giant Regeneron Hit As Eylea Gives Ground To Avastin
January 09, 2023
Via
Investor's Business Daily
Twitter Hackers Stole More Than 200M Emails, Delta Air Lines To Offer Free Wi-Fi, Bed Bath & Beyond's Bankruptcy Coming Sooner Than Expected: Top Stories Today
January 06, 2023
Via
Benzinga
Roche's Investigational Lymphoma Candidate Goes Under FDA Priority Review
January 06, 2023
Via
Benzinga
FDA Grants Priority Review to Genentech’s Bispecific Antibody Glofitamab for People With Relapsed or Refractory Large B-Cell Lymphoma
January 06, 2023
From
Genentech
Via
Business Wire
Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?
January 05, 2023
Via
Investor's Business Daily
Better Large-Cap Buy: Roche Holding or Gilead Sciences Stock?
January 02, 2023
Via
The Motley Fool
Big Health Care Stocks to Watch in the New Year
December 29, 2022
Via
MarketBeat
The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock
December 28, 2022
Via
Investor's Business Daily
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
Via
Benzinga
FDA Approves Genentech’s Lunsumio, a First-in-Class Bispecific Antibody, to Treat People With Relapsed or Refractory Follicular Lymphoma
December 22, 2022
From
Genentech
Via
Business Wire
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
Via
Benzinga
Crispr Stock In 2023: Will Down-In-The-Dumps Shares Sparkle Again In 2023?
December 22, 2022
Via
Investor's Business Daily
Top Biotech Companies Are Making Steady Progress In Developing Treatments To Fight Alzheimer’s Disease
December 21, 2022
Via
Talk Markets
FDA Approves Genentech’s Actemra for the Treatment of COVID-19 in Hospitalized Adults
December 21, 2022
From
Genentech
Via
Business Wire
Gilead Sciences (GILD) Stock Falls on Lung Cancer Drug Data
December 20, 2022
Via
InvestorPlace
Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche
December 20, 2022
Via
Investor's Business Daily
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
December 19, 2022
Via
MarketBeat
OTC Market Group’s Most Active List In November: A Dive Into The Names Experiencing Volume Changes
December 14, 2022
Via
TheNewswire.com
Topics
ETFs
Economy
Stocks
Exposures
Interest Rates
US Equities
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.